Detalhe da pesquisa
1.
SARS-CoV-2 Variants and Vaccines.
N Engl J Med
; 385(2): 179-186, 2021 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161052
2.
Enabling the evaluation of COVID-19 vaccines with correlates of protection.
Biologicals
; 85: 101723, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976940
3.
Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals.
Biologicals
; 67: 94-111, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32660862
4.
Global harmonization of vaccine testing requirements: Making elimination of the ATT and TABST a concrete global achievement.
Biologicals
; 63: 101-105, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699501
5.
Emergency Use Authorization of Covid Vaccines - Safety and Efficacy Follow-up Considerations.
N Engl J Med
; 383(19): e107, 2020 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064383
6.
Detection of bovine viral diarrhoea virus nucleic acid, but not infectious virus, in bovine serum used for human vaccine manufacture.
Biologicals
; 55: 63-70, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941334
7.
Clinical Development Strategies and Considerations for Zika Vaccine Licensure.
J Infect Dis
; 216(suppl_10): S964-S970, 2017 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29267913
8.
Considerations in boosting COVID-19 vaccine immune responses.
Lancet
; 398(10308): 1377-1380, 2021 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34534516
9.
Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations.
J Infect Dis
; 209 Suppl 1: S28-31, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24626869
10.
Predictive markers of safety and immunogenicity of adjuvanted vaccines.
Biologicals
; 41(6): 458-68, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24071553
11.
Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19.
Front Immunol
; 14: 1109486, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817425
12.
Influenza immunization during pregnancy: US regulatory perspective.
Am J Obstet Gynecol
; 207(3 Suppl): S57-62, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22920061
13.
Evolving pharmacovigilance requirements with novel vaccines and vaccine components.
BMJ Glob Health
; 6(Suppl 2)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011500
14.
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
Vaccine
; 39(51): 7357-7362, 2021 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799142
15.
Global and national initiatives to facilitate studies of vaccines in pregnant women.
Clin Infect Dis
; 59 Suppl 7: S395-9, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25425717
16.
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary.
NPJ Vaccines
; 9(1): 82, 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38684704
17.
Current status of monkeypox vaccines.
NPJ Vaccines
; 7(1): 94, 2022 Aug 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977979
18.
Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation.
Vaccine
; 40(40): 5749-5751, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35941036
19.
An overview of the regulation of influenza vaccines in the United States.
Influenza Other Respir Viruses
; 10(5): 354-60, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27426005
20.
The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
Vaccine
; 33(47): 6499-500, 2015 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26256527